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ABSTRACT. D-dimers are small protein fragments present in the blood after a blood clot is degraded by plasmin. During the 
fibrin(ogen) degradation, a number of products are produced called fibrin(ogen) degradation products (FDPs). D-dimers are 
part of the FDPs, formed as a result of plasmin activity on cross-linked fibrin. Thus, D-dimers indicate the activity of both trombin 
and plasmin and are specific markers for fibrinolysis. D-dimer measurement is widely used in the diagnostic work-up of human 
patients as the most sensitive test to diagnose pulmonary thromboembolism (PTE) and disseminated intravascular coagulation 
(DIC) and it is, also, considered essential in the evaluation of antithrombotic therapy. During the last decade, there was 
considerable research regarding the potential utility of D-dimer in veterinary medicine, particularly in canine and equine species. 
In dogs, D-dimer plasma concentrations can be used to rapidly detect the thrombotic complications and DIC associated with 
many systemic diseases (high quantitative D-dimer levels). The symptoms of PTE are subtle and the confirmation of diagnosis 
with routine hematological tests can be difficult, thus jeopardizing the patient's survival. Several techniques have been employed 
for the detection of D-dimer; the immunoenzymatic assay (ELISA), the immuno-turbidimetric assay and several latex agglutination 
assays are more commonly used. 
Keywords: D-dimers, dog, DIC, thromboembolism 
ΠΕΡΙΑΗΨΗ. Τα δ-διμερή είναι προϊόντα αποδόμησης του ινώδους (FDPs) που παράγονται με την επίδραση της πλασμίνης 
στα πολυμερή του ινώδους. Αποτελούν έτσι δείκτες της δραστηριότητας της θρομβίνης και της πλασμίνης και, επομένως, της 
ινωδόλυσης. Ειδικότερα, τα δ-διμερή είναι ένα από τα προϊόντα αποδόμησης των πολυμερών του ινώδους που έχουν υποστεί 
διασταυρούμενη ανασύνδεση. Κατά τη δευτερογενή, ενδογενή ή εξωγενή αιμόσταση, ενεργοποιείται ο παράγοντας Χ της 
πήξης του αίματος. Μέσω αυτού γίνεται η μετατροπή του παράγοντα II σε Πα, ο οποίος με τη σειρά του συμμετέχει στη 
μετατροπή του ινωδογόνου σε μονομερή του ινώδους (τα οποία πολυμερίζονται) και του παράγοντα XIII σε ΧΙΙΙα. Ο 
παράγοντας ΧΙΙΙα προκαλεί διασταυρούμενη σύνδεση των μονομερών του ινώδους, δημιουργώντας μεγαλύτερες και ισχυρότερες 
ίνες ινώδους. Κατά την ινωδόλυση, στη συνέχεια, δημιουργούνται τα FDPs, ένα από τα οποία είναι και τα δ-διμερή, που προ­
έρχονται αποκλειστικά από τα διασταυρούμενα μονομερή του ινώδους, συνδέοντας έτσι την ανίχνευση τους με ενεργή πήξη -
ινωδόλυση. Τα δ-διμερή έχουν μεγαλύτερη ευαισθησία στη διάγνωση του Συνδρόμου Διάσπαρτης Ενδοαγγειακής Πήξης 
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(ΣΔΕΠ) σε σύγκριση με τα FDPs, καθώς ανιχνεύουν τόσο την ύπαρξη πρόσφατα σχηματισμένου θρόμβου, όσο και την 
ταυτόχρονη αποδόμησή του. Στην Ιατρική, η ποσοτική ανίχνευση των δ-διμερών χρησιμοποιείται κυρίως για την έγκαιρη 
διάγνωση της θρομβοεμβολής και του ΣΔΕΠ, καθώς και στην αξιολόγηση της αντιθρομβωτικής θεραπείας. Αντίστοιχες 
παθολογικές καταστάσεις έχουν διαπιστωθεί και στο σκύλο, στη διερεύνηση των οποίων θα μπορούσε ενδεχομένως να συμβάλει ο 
προσδιορισμός των δ-διμερών. Η διάγνωση του ΣΔΕΠ στο στάδιο της υπερπηκτικότητας είναι δύσκολη επειδή τα συμπτώματα δεν 
είναι ειδικά, γεγονός που καθυστερεί την έναρξη της αντιθρομβωτικής θεραπείας, με επακόλουθο την αυξημένη θνησιμότητα. Στο 
σκύλο, η μέτρηση των δ-διμερών φαίνεται ότι μπορεί να συμβάλει ουσιαστικά στη διάγνωση της θρομβοεμβολής και του ΣΔΕΠ, 
επειδή η συγκέντρωση τους αυξάνει σημαντικά και στις δύο αυτές παθολογικές καταστάσεις. Για τον προσδιορισμό των δ-διμερών 
στο αίμα του σκύλου χρησιμοποιείται η μεθοδολογία που εφαρμοζόταν αρχικά στον άνθρωπο και, συγκεκριμένα, η ανοσοενζυμική 
μέθοδος ELISA, η ανοσοφωταύγεια και η συγκόλληση. Οι μέθοδοι αυτοί έχουν αξιολογηθεί ως προς την ευαισθησία και την 
ειδικότητα τους στο σκύλο. 
Λέξεις ευρετηρίασης: δ-διμερή, σκύλος, Σύνδρομο Διάχυτης Ενδοαγγειακής Πήξης, θρομβοεμβολή 
INTRODUCTION 
Hemostatic abnormalities are commonly reported in veterinary medicine (Feldman 1999). As a rule, an 
hemostatic abnormality occurs with excessive bleeding; 
occasionally, abnormal hemostatic mechanisms can, also, 
cause thromboembolism (TE) (Allison and Meinkoth 
2007). Even though disseminated intravascular 
coagulation (DIC) is considered to be a relatively 
common syndrome in dogs, the diagnosis of fulminant 
DIC is difficult to be confirmed by the traditional 
hemostatic profile. D-dimer concentration may permit 
early diagnosis and more precise classification of 
coagulopathies in some species (Monreal 2003). The 
purpose of this article is to review the use of D-dimer 
as a diagnostic tool in canine internal medicine. 
AN OVERVIEW OF HEMOSTASIS AND ITS 
COMMON ABNORMALITIES 
Hemostasis is a highly controlled balance between 
coagulation and fibrinolysis. The mechanisms of 
coagulation and fibrinolysis are briefly presented in 
figures 1 and 2. Hemostasis depends on the integrity 
of blood vessels, platelet counts and function, 
coagulation factors, fibrinolytic factors, as well as 
coagulation inhibitors. Disruption of any of these 
components may result in hemorrhage or thrombosis. 
Primary hemostatic defects are characterized by the 
presence of superficial cutaneous and mucosal bleeding 
and they are usually caused by thrombocytopenia, while 
liver disease and rodenticide poisoning leading to 
vitamin Κ deficiency are the leading causes of 
secondary hemostatic defects (Couto 2003). DIC is a 
complex syndrome in which excessive intravascular 
coagulation leads to multiple-organ microthrombosis 
and paradoxical bleeding caused by the inactivation or 
excessive consumption of platelets and clotting factors 
secondary to enhanced fibrinolysis. 
Thrombosis is the formation of thrombi within the 
vascular system. Thrombi are formed when the normal 
balance between prothrombotic and anti-thrombotic 
factors shift to favour thrombosis. Clinical signs 
depend on the underlying disease and location of the 
lesion (Stockham and Scott 2002). Pulmonary throm­
boembolism (PTE) is a significant, under-diagnosed 
complication in small animals. 
DIAGNOSTIC SIGNIFICANCE OF D-DIMER VS 
FIBRIN DEGRADATION PRODUCTS 
D-dimer is a specific product of the plasmin 
mediated lysis of cross-linked fibrin (Stokol 2003, 
Ware et al. 2007, Hackner 2009a, Hackner 2009b). The 
activation of the coagulation cascade may follow the 
intrinsic and/or the extrinsic pathway. No matter which 
pathway is activated, factor X is converted to factor Xa. 
In the presence of Ca2+, Factor Xa and factor Va form 
the prothrombinase complex, which converts 
prothrombin (factor II) to thrombin (factor Ha). 
Thrombin converts factor XIII to factor XHIa and it, 
also, cleaves fibrinopeptides A and Β from the central 
E region of fibrinogen to form fibrin monomers, which 
in contrast to fibrinogen can polymerize to form 
protofibrils. Factor XHIa cross-links adjacent D regions 
of different fibrin monomers to form stable cross-
linked fibrin protofibrils and thus a stable thrombus. 
The Fibrin degradation products (FDPs) are 
generated when plasmin cleaves fibrin and fibrinogen 
at specific sites to form several fibrin and fibrinogen 
fragments. In contrast, plasmin-mediated degradation 
of cross-linked fibrin produces a different set of FDPs 
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because of the covalent bonds formed by 
factor XHIa between adjacent D regions 
(D-dimers) (Stockham and Scott 2002). 
D-dimer formation is briefly depicted 
in figures 3 and 4. It is illustrated that D-
dimer detection requires activation of both 
thrombin and plasmin; thrombin to 
produce fibrin from fibrinogen and to 
activate factor XIII to produce the cross­
links and plasmin for fibrinolysis of the 
cross-linked fibrin, exposing the 
neoepitopes created by the cross-linking 
process. Therefore, D-dimer assay is a 
diagnostic tool with higher specificity in 
thromboembolic disorders. 
Blood Coagulation 
Extrinsic or Intrinsic 
Activation factor X * = > factor Xa 
Prothrombin (factor D z> Thrombin (factor 
1. Cleaves fibrinopeptidesA,B 2. Activates factor ΧΠΕ 
from fibrinogen Ç factor XDb 
Soluble fibrin monomers 
J [ Polymerization 
Protofibrils 
n 
GOSHinted fibrin Protofibrils 
D-DIMER IN HUMAN MEDICINE 
The clinical value of D-dimer assays 
has been the objective of numerous studies 
in human medicine (Righini et al. 2008, 
Adamet al. 2009). In practice, D-dimer 
assays have been validated in the exclusion 
of deep vein thrombosis and/or pulmonary 
embolism in certain patient populations, 
since this cannot be achieved on clinical 
grounds alone. Deep-vein thrombosis can 
be confidently ruled out in a patient with 
low risk for deep-vein thrombosis and a 
negative D-dimer test. Ultrasound testing 
can be safely omitted in such patients 
(Wells et al. 2003). Due to its high negative 
predictive value (>92%), D-dimer 
measurement has been used to predict the 
risk of thrombosis recurrence and to 
individualize anticoagulant therapy 
(Righini and Perrier 2008). 
Measurements of D-dimer may, also, 
be used along with other tests to help diagnose DIC. 
DIC is a complex hemostatic abnormality arising from 
a variety of underlying conditions, including surgical 
procedures, septic shock, poisonous snake bites, liver 
disease and postpartum disorders. With DIC, clotting 
factors are activated and then used up throughout the 
body, resulting in extensive vascular microthrombosis, 
while, at the same time, the patient appears vulnerable 
to excessive bleeding. D-dimer levels may be used to 
monitor the effectiveness of DIC treatment. A 
sensitive, immunoturbidimetric D-dimer assay, which 
was validated and clinically evaluated, was found to 
Figure 1. Schematic presentation of coagulation 
Fibrinolysis 
Fibrin- Fibrinogen Cross-linked fibrin protofibrils 
Pfasnin I 
FDPs d-dimer 
Ptasnin 
D-dimer are generated after the action of both Thrombin 
and Plasmin »- .,» active Coagulati on and Fibrinolysis 
Figure 2. Schematic presentation of fibrinolysis 
provide excellent sensitivity and negative predictive 
value for the diagnosis of DIC (Lehman et al. 2004). 
D-DIMER IN VETERINARY MEDICINE 
In veterinary medicine, most of the publications on 
D-dimer refer to companion animals and equines 
rather than livestock. However, an increase in D-dimer 
has been reported in cattle with left abomasal 
displacement (Sobiech et al. 2008). There is evidence 
that cattle with abomasal displacement have 
hemostatic dysfunction and that DIC is a significant 
risk factor for mortality (Irmak and Turgut 2005). 
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Figure 3. Schematic presentation of d-
dimer formation 
The fibrinogen molecule is represented 
with a central (E) and two satellite (D) 
parts. Fibrinopeptide A and Β are cleaved 
from the Ε-part resulting to the formation 
of fibrin monomers, which then 
polymerize to form a large molecule. 
Fibrinogen 
D E D 
R bri nopept ides 
A Β 
hfl-fl 
Soluble fibrin monomers 
: > 
E* 
Figure 4. 
Soluble fibrin polymer is converted to 
cross-linked fibrin by factor XHIa. These 
cross-links form a very strong bond 
between the D-domains, thus producing 
neoepitopes in fibrin that become exposed 
after plasmin digestion of fibrin. This new 
molecule that derives from two D-domains 
of adjacent cross-linked fibrils, represents 
a D-dimer molecule. 
ΞΗΤΊ-ΞΧΙ-β-1 
chcfmsr 
Regarding the use of D-dimer in equine medicine, 
a previously validated D-dimer assay was found to 
improve the prognostic ability in colic cases that are 
usually accompanied by DIC. Furthermore, it was 
found that healthy horses have detectable 
concentrations of serum FDPs and D-dimer and a high 
D-dimer concentration supports the diagnosis of DIC, 
while FDPs were not useful for the diagnosis of DIC in 
this species (Sandholm et al. 1995, Stokol et al. 2005). 
In another study (Armengou et al. 2008) on the plasma 
D-dimer concentration in sick newborn foals, it was 
found that increased values are significantly associated 
with sepsis. Due to the marked hypercoagulation and 
hyperfibrinolysis that occurs in septic neonates, the 
inclusion of D-dimer assay in the minimal database of 
critical newborn foals during their hospitalization is 
well justified. However, based on the results of this 
study, the relationship between D-dimer concentration 
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and DIC needs further assessment. 
An immunoturbidimetric D-dimer assay for DIC 
in cats was validated and its diagnostic utility was 
assessed (Brazzell and Borjesson 2007). Although 
thromboembolism is a well-known complication of 
feline cardiomyopathy, D-dimer concentrations in cats 
with cardiomyopathy were not significantly different 
compared to healthy cats. Other D-dimer assays, 
potentially more efficient, should be evaluated in cats. 
Moreover, feline plasma may contain a substance that 
interferes with the specific assay. This has been 
observed with human neutrophil elastase that degrades 
D-dimers (Bach-Gansmo et al. 1996). 
D-DIMER AS A DIAGNOSTIC TOOL IN COMMON 
HYPERCOAGULABLE STATES IN DOGS 
D-dimer indicates the activation of both thrombin 
and plasmin (thus being specific for fibrinolysis) and it 
can be an important tool in detecting TE and DIC in 
dogs. D-dimer concentrations are increased in several 
other disorders, such as immune-mediated hemolytic 
anemia (IMHA), surgical procedures, cancer, liver 
disease, heart failure, renal failure and internal 
hemorrhage (Stokol 2003). 
PTE is probably underdiagnosed in veterinary 
patients due to technical limitations and the subtle, 
nonspecific clinical signs. The fact that thrombi dissolve 
fast makes their identification difficult during post­
mortem examination. PTE could mimic other clinical 
disorders, such as pneumonia, pulmonary edema, lung 
cancer and pleural effusions and, furthermore, it occurs 
almost exclusively secondary to one or more underlying 
conditions. Any suspicion of PTE should prompt a 
thorough investigation for these conditions (Hackner 
2009b). Most dogs with PTE present simultaneously 
protein loss nephropathies or neoplasia, suggesting that 
these disorders could be associated with a higher risk 
of developing PTE (Nelson and Andreasen 2003). 
Even though a diagnosis of PTE in human medicine is 
made with the simultaneous evaluation of several 
laboratory tests, high values of D-dimer increase 
significantly the possibility of PTE (Tick et al. 2008). 
Similarly, in a canine study, the healthy control dogs 
had D-dimer values less than 250 ng/mL, whereas dogs 
with PTE had values over 2.000 ng/mL and a prediction 
specificity of 98.5%. For D-dimer values between 1.000 
and 2.000 ng/mL, the specificity was 94% (Nelson and 
Andreasen 2003). 
Sepsis seems to have an effect in D-dimer 
concentration. De Laforcade et al (2003), in a study 
using similar assay for measuring D-dimer in dogs with 
naturally occurring sepsis, found that dogs with sepsis 
have a significantly higher D-dimer value compared to 
healthy controls. Four out of 20 septic dogs had values 
higher than 2.000 ng/mL. One dog had TE and 5 dogs 
had DIC (de Laforcade et al. 2003). Unfortunately, 
there was no reference to whether these dogs were 
among the ones with the highest values, a fact that would 
amplify the results from Nelson and Andreasen (2003). 
Dogs with congestive heart failure (Tarnow et al. 
2007) and immune-mediated hemolytic anaemia (Scott-
Moncrieff et al. 2001) were presented with increased D-
dimer values. In another study, dogs with malignant 
tumors had, also, higher D-dimer values compared to 
dogs with benign tumors (Kristensen et al. 2008). 
DIC is the most serious acquired thromboembolic 
and hemorrhagic disorder affecting dogs. It is always a 
consequence of other diseases, including sepsis, 
neoplasia and immune-mediated hemolytic anaemia 
(Stokol 2003). A final diagnosis is not possible based 
on a single diagnostic examination, whereas the 
combination of clinical evaluation and laboratory tests 
will confirm it. The use of D-dimer assays for early DIC 
recognition has proven to be significant (Caldin et al. 
2000, Stokol et al. 2000). Besides, D-dimer value is 
quite higher in dogs that died of DIC in contrast to 
those who survived (Wiinberg et al. 2008). The 
presence of high plasma D-dimer value is compatible 
with activated fibrinolysis usually in favour of DIC 
(Brooks 2006). 
D-dimers have a half life of approximately 5 hours, 
thus their detection is useful in active or recent 
fibrinolysis (Hackner 2009a, Hackner 2009b). In a 
study by Marsh et al. (1994), D-dimers appeared in the 
blood of healthy dogs within an hour of thrombus 
induction, their concentration peaked 4 hours later and 
remained elevated even after 24 hours. Similar results 
were presented in another study in which D-dimer 
concentration was significantly elevated within 30 
minutes, 1, 2, 4 and 24 hours, respectively, after 
experimental induction of PTE (Ben et al. 2007). 
METHODS FOR D-DIMER DETERMINATION 
Several techniques are currently available for D-
dimer measurement, using monoclonal antibodies raised 
against the D-dimer epitope. Among these methods, 
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those based on the enzyme-linked immunosorbent assay 
(ELISA) and agglutination (latex agglutination or 
immune-turbidimetric assay) are the most commonly 
used (Caldin et al. 2000, Stokol et al. 2005, Boutet et al. 
2009). 
ELISA methods were initially developed for 
research purposes before the latex agglutination 
assays. Several technological advances in assay format 
and instrumentation led to ELISA-based assays that 
have increased sensitivity and are capable of detecting 
elevated D-dimer antigen associated with a variety of 
clinical disorders in human medicine (Perrier et al. 
1997). Various D-dimer tests that use monoclonal 
antibodies to human D-dimer have been validated for 
use in veterinary medicine. However, the only 
commercially available ELISA D-dimer test that has 
been studied in veterinary medicine (Griffin et al. 
2003) is no longer marketed by its manufacturer 
(Stokol 2003). 
Latex agglutination tests are qualitative tests, quick 
and easy to perform, inexpensive and not requiring 
specialized equipment (Nelson and Andreasen 2003). 
A sensitivity of 100% with a specificity of 97% has been 
reported (Stokol et al. 2000). An immunometric "Point-
of-Care" test has been used in healthy dogs (Wiinberg 
et al. 2007), dogs with chronic congestive heart failure 
(Tarnow et al. 2007) and in clinically ill dogs with and 
without TE/DIC (Dewhurst et al. 2008). In the latter 
study, D-dimer test was found to be an easy to use test, 
which could aid in a first opinion practice. 
Immunorurbidimetric assays use antibody-coated 
beads that react with D-dimer, producing changes in 
sample turbidity, which are read by an automated 
analyzer. They are quantitative, sensitive, readily 
automated and less prone to technical error than latex 
agglutination tests (Stokol 2003). The immuno-
turbidimetric technique was found to be reliable and 
accurate, since it conforms to the current standard of 
precision, linearity and accuracy. However, the clinical 
specificity and sensitivity of the above method was not 
assessed (Caldin et al. 2000). In a comparative study 
(Boutet et al. 2009) between the latex agglutination 
test and the immunoturbidimetric assay, in which both 
tests were based on the same monoclonal antibody, the 
immunoturbidimetric assay had good concordance 
with the latex-agglutination test, but it, also, offers the 
advantage of speed and eventual automation. 
Citrate is a commonly used anticoagulant to collect 
samples for routine coagulation tests (Allison and 
Meinkoth 2007). Both citrate and EDTA tubes have 
been used for collection of blood samples for D-dimer. 
However, citrate tubes are preferable, since storage for 
2 hours significantly affected values for EDTA-treated 
plasma samples (Ceron et al. 2008). 
Regarding the stability of D-dimer in canine 
plasma, it has been reported that storage of plasma for 
2 days at room temperature does not have any 
significant effect on most of the hemostatic parameters 
of canine plasma including D-dimer (Furlanello et al. 
2006). Furthermore, hemolysis had no significant 
effect on D-dimer concentration when samples were 
stored refrigerated or frozen or even in room 
temperature, if samples were measured within 24 
hours. D-dimer was stable in non-hemolysed samples 
stored at -20° C for up to 1 month after collection 
(Stokol et al. 2000, Boutet et al. 2009). 
CONCLUSION 
D-dimer evaluation for the diagnosis of PT and DIC 
in dogs has shown a promising diagnostic potential. 
Although the predictive value of a positive result seems 
to be limited, recent studies support the use of D-dimer 
tests always in conjunction with the widely used tests for 
coagulation in the appropriate clinical context. 
Furthermore, due to the high negative predictive value, 
they can be used in the diagnosis and the monitoring of 
antithrombotic therapy. Further method development 
and validation of species specific D-dimer assay will play 
a critical role in the reliability of results. Finally, 
interpretation of results based on clinical evidence will 
improve diagnosis and, ultimately, clinical decisions. • 
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